AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 74 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $144,000 | +71.4% | 6,500 | 0.0% | 0.00% | – |
| Q2 2021 | $84,000 | 0.0% | 6,500 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $84,000 | -6.7% | 6,500 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $90,000 | -6.2% | 6,500 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $96,000 | -9.4% | 6,500 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $106,000 | +12.8% | 6,500 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $94,000 | -28.8% | 6,500 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $132,000 | +277.1% | 6,500 | 0.0% | 0.00% | – |
| Q3 2019 | $35,000 | -18.6% | 6,500 | 0.0% | 0.00% | – |
| Q2 2019 | $43,000 | +2.4% | 6,500 | 0.0% | 0.00% | – |
| Q1 2019 | $42,000 | -4.5% | 6,500 | 0.0% | 0.00% | – |
| Q4 2018 | $44,000 | +2.3% | 6,500 | 0.0% | 0.00% | – |
| Q3 2018 | $43,000 | +16.2% | 6,500 | 0.0% | 0.00% | – |
| Q2 2018 | $37,000 | +8.8% | 6,500 | 0.0% | 0.00% | – |
| Q1 2018 | $34,000 | +17.2% | 6,500 | 0.0% | 0.00% | – |
| Q4 2017 | $29,000 | -29.3% | 6,500 | 0.0% | 0.00% | – |
| Q3 2017 | $41,000 | +2.5% | 6,500 | 0.0% | 0.00% | – |
| Q2 2017 | $40,000 | -16.7% | 6,500 | 0.0% | 0.00% | – |
| Q1 2017 | $48,000 | – | 6,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 111,608 | $2,470,000 | 3.15% |
| ACT CAPITAL MANAGEMENT, LLC | 180,000 | $3,983,000 | 2.06% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 167,889 | $3,715,000 | 1.92% |
| DG Capital Management, LLC | 402,200 | $8,901,000 | 1.81% |
| NEA Management Company, LLC | 5,172,683 | $114,471,000 | 1.36% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 801,100 | $17,728,000 | 0.99% |
| Altium Capital Management LP | 144,000 | $3,187,000 | 0.84% |
| HighMark Wealth Management LLC | 50,569 | $1,119,000 | 0.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 123,500 | $2,724,000 | 0.66% |
| SEVEN EIGHT CAPITAL, LP | 288,840 | $6,392,000 | 0.62% |